08/28/2024
3:30 PM | GOOD JENNIFER L (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/28/2024
3:31 PM | Rhythm Pharmaceuticals (Issuer)
TETRAULT LYNN A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/28/2024
3:31 PM | Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2024
3:26 PM | Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/26/2024
3:27 PM | Rhythm Pharmaceuticals (Subject)
TETRAULT LYNN A. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/26/2024
3:27 PM | GOOD JENNIFER L (Reporting)
Rhythm Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/13/2024
3:45 PM | Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
08/12/2024
3:13 PM | Rhythm Pharmaceuticals (Subject)
TETRAULT LYNN A. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024
5:00 AM | Rhythm Pharmaceuticals (Filer)
| Form DEFR14A | |
08/07/2024
5:03 AM | Rhythm Pharmaceuticals (Filer)
| Form DEFA14A | |
08/06/2024
6:00 AM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/30/2024
4:09 PM | Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2024
4:59 PM | Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2024
3:30 PM | Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2024
3:37 PM | Rhythm Pharmaceuticals (Subject)
Shulman Joseph (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/12/2024
3:34 PM | Rhythm Pharmaceuticals (Subject)
Shulman Joseph (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2024
4:00 PM | Garfield Alastair (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/10/2024
4:01 PM | Garfield Alastair (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2024
3:05 PM | Rhythm Pharmaceuticals (Filer)
| Form 424B7 | |
07/10/2024
3:07 PM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/25/2024
3:39 PM | MCGIRR DAVID W J (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
3:41 PM | Arbuckle Stuart A (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
3:30 PM | GOOD JENNIFER L (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
3:35 PM | JEAN CHRISTOPHE (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
3:37 PM | Bedrosian Camille L (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
3:38 PM | Mathers Edward T (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
3:38 PM | Rhythm Pharmaceuticals (Issuer)
TETRAULT LYNN A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
8:44 PM | MCGIRR DAVID W J (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
8:47 PM | Rhythm Pharmaceuticals (Issuer)
TETRAULT LYNN A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
8:38 PM | Arbuckle Stuart A (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
8:39 PM | GOOD JENNIFER L (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
8:41 PM | Bedrosian Camille L (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
8:42 PM | JEAN CHRISTOPHE (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
8:43 PM | Mathers Edward T (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
4:28 PM | Rhythm Pharmaceuticals (Filer)
| Form DEFA14A | |
06/17/2024
4:19 PM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
3:43 PM | Rhythm Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/07/2024
6:10 AM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2024
6:31 PM | NEW ENTERPRISE ASSOCIATES 13 LP (Filed by)
Rhythm Pharmaceuticals (Subject)
| Form SC 13D/A | |
04/26/2024
3:13 PM | Rhythm Pharmaceuticals (Filer)
| Form ARS | |
04/17/2024
3:15 PM | PERCEPTIVE ADVISORS LLC (Filed by)
Rhythm Pharmaceuticals (Subject)
| Form SC 13D/A | |
Kamala’s Dirty Election Move… Revealed (Ad) According to former advisor to the CIA, the Pentagon and the White House Jim Rickards…
Kamala and her puppet masters are planning this dirty election move…
 Click here now and learn how to prepare. |
04/16/2024
7:11 PM | Mazabraud Yann (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2024
6:00 AM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/03/2024
7:00 PM | German Christopher Paul (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
5:18 PM | PERCEPTIVE ADVISORS LLC (Filed by)
Rhythm Pharmaceuticals (Subject)
| Form SC 13D/A | |
04/01/2024
4:25 PM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/22/2024
3:55 PM | Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
3:21 PM | Rhythm Pharmaceuticals (Subject)
Shulman Joseph (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2024
4:51 PM | PERCEPTIVE ADVISORS LLC (Filed by)
Rhythm Pharmaceuticals (Subject)
| Form SC 13D | |
03/20/2024
3:41 PM | Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/19/2024
7:50 PM | Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:52 PM | Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:53 PM | Mazabraud Yann (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:54 PM | Meeker David P (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:56 PM | Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:57 PM | Rhythm Pharmaceuticals (Issuer)
Smith Hunter C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
3:58 PM | Rhythm Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/29/2024
3:44 PM | Rhythm Pharmaceuticals (Filer)
| Form 424B5 | |
02/29/2024
3:46 PM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/29/2024
3:05 PM | Rhythm Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/22/2024
6:01 AM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/21/2024
6:00 PM | Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
6:00 PM | Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
6:01 PM | Rhythm Pharmaceuticals (Issuer)
Smith Hunter C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
6:01 PM | Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
6:02 PM | German Christopher Paul (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
6:02 PM | Mazabraud Yann (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
6:03 PM | Meeker David P (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
5:14 PM | Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
7:45 PM | Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
7:46 PM | Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
7:47 PM | Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
7:49 PM | Mazabraud Yann (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
7:50 PM | Rhythm Pharmaceuticals (Issuer)
Smith Hunter C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
4:13 PM | Rhythm Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G | |
02/09/2024
3:19 PM | Rhythm Pharmaceuticals (Subject)
Shulman Joseph (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/05/2024
5:53 PM | Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
5:53 PM | Meeker David P (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
5:54 PM | Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
5:54 PM | Rhythm Pharmaceuticals (Issuer)
Smith Hunter C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
5:55 PM | Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
4:34 PM | GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
Rhythm Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/24/2024
8:46 AM | BlackRock Inc. (Filed by)
Rhythm Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/23/2024
8:04 AM | Rhythm Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/04/2024
6:15 AM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
6:00 AM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2024
3:15 PM | Rhythm Pharmaceuticals (Issuer)
Smith Hunter C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
3:30 PM | Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2023
3:22 PM | Rhythm Pharmaceuticals (Subject)
Shulman Joseph (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/18/2023
3:16 PM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2023
3:30 PM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Tim Sykes’ Urgent Trade Alert: “Make this move now” (Ad) WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock
This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race… Click here to see a unique election-year trade |
12/06/2023
3:34 PM | Rhythm Pharmaceuticals (Subject)
Smith Hunter C (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/24/2023
12:06 PM | Rhythm Pharmaceuticals (Subject)
Smith Hunter C (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2023
3:14 PM | Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2023
3:14 PM | Rhythm Pharmaceuticals (Subject)
Shulman Joseph (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/13/2023
4:44 PM | Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2023
3:30 PM | Rhythm Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/08/2023
3:14 PM | Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/07/2023
5:17 PM | Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2023
6:05 AM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
